Novo Nordisk, Ypsomed and CagriSema
As sales of Novo Nordisk’s GLP-1 drugs for diabetes and obesity continue to soar, the Danish drugmaker is once again ...
Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. The Danish drugmaker ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...
LONDON, Nov 14 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing ...
MSF also wants the company to lower prices for other insulin products. Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid ...
MSF also wants the company to lower prices for other insulin products. Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid ...